Kazuhiro Yamamoto
4PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jun 13, 2025
Safety and effectiveness of empagliflozin in Japanese patients with heart failure: a 1-year post-marketing surveillance study stratified by age.Kazuhiro Yamamoto, Yusuke Naito, Sakurako Watanabe
|Nov 27, 2024
Clinical Phenotypes Associated with the Gut Microbiome in Older Japanese People with Care Needs in a Nursing Home.Rikako Inoue, Koji Hosomi, Jonguk Park
|Apr 05, 2022
Safety and effectiveness of empagliflozin according to body mass index in Japanese patients with type 2 diabetes: a subgroup analysis of a 3-year post-marketing surveillance study.Kohei Kaku, Kazuhiro Yamamoto, Yumiko Fukushima
|Mar 22, 2022
Safety and effectiveness of empagliflozin in Japanese patients with type 2 diabetes: final results of a 3-year post-marketing surveillance study.Kohei Kaku, Kazuhiro Yamamoto, Yumiko Fukushima
Pageof 1
Frequent Collaborators
2 joint publications
Kohei Kaku
1 joint publications
Atsutaka Yasui
1 joint publications
Daisuke Nitta
1 joint publications
Rikako Inoue
1 joint publications
Jonguk Park
1 joint publications
Miki Doi
1 joint publications
Kenji Mizuguchi
1 joint publications
Yasuyuki Irie
1 joint publications
Yusuke Naito
1 joint publications
Sakurako Watanabe
